Metabolic Fingerprint of Dual Body Fluids Deciphers Diabetic Retinopathy
Small · 2025-03 · 21 (10)
DOI: 10.1002/smll.202412195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 28.01.2025. Verfasst von Yihan Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Oncogenes and Related Genes, School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, S…. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Metabolomics, Body Fluids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key R&D Program, Medical-Engineering Joint Funds of Shanghai Jiao Tong University, Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is a microvascular complication of diabetes, affecting 34.6% of diabetes patients worldwide. Early detection and timely treatment can effectively improve the prognosis of DR. Metabolomic analysis provides a powerful tool for studying pathophysiological processes. Conducting metabolomic analyses on DR‐related biofluids helps identify differential metabolic expressions during disease progression, thereby discovering potential biomarkers to support clinical diagnosis and treatment. Here, an innovative workflow for vitreous liquid analysis is established, and a machine learning‐based DR analysis platform integrating vitreous liquid metabolic fingerprint (VL‐MF) and plasma metabolic fingerprint (P‐MF) derived via nanoparticle enhanced laser desorption/ionization mass spectrometry is developed. Direct VL‐MF and P‐MF are obtained with desirable reproducibility (coefficient of variation, CV
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Oncogenes and Related Genes, School of Biomedical Engineering, Institute of Medical Robotics and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.
- Department of Ophthalmology, National Clinical Research Center for Eye Diseases, Shanghai Gene Therapy Center, Shanghai Key Laboratory of Ocular Fundus Disease, Shanghai General Hospital, Shanghai Jiao Tong University S…
- Department of Chemical Engineering, The University of Warwick, Coventry, CV4 8UW, UK.
- Department of Ophthalmology, National Clinical Research Center for Eye Diseases, Shanghai Gene Therapy Center, Shanghai Key Laboratory of Ocular Fundus Disease, Shanghai Engineering Center for Visual Science and Photome…
ORCID-Profile: Shunxiang Li, Kun Qian
Förderung
- National Key R&D Program
- Medical-Engineering Joint Funds of Shanghai Jiao Tong University
- Natural Science Foundation of China
- Shanghai Jiao Tong University Inner Mongolia Research Institute
- Sichuan Science and Technology Program
- Shanghai Institutions of Higher Learning
- National Clinical Key Specialty Construction Project
- Shanghai Science and Technology Development Funds
Zitieren
APA
Wang, Y., Li, S., Li, T., Wu, J., Huang, Y., Liu, W., Ding, C., Huang, L., Xu, X., Wang, Y., Gu, S., Liu, K., Qian, K., & Sun, X. (2025). Metabolic Fingerprint of Dual Body Fluids Deciphers Diabetic Retinopathy. Small, 21(10). https://doi.org/10.1002/smll.202412195
Vancouver
Wang Y, Li S, Li T, Wu J, Huang Y, Liu W, et al. Metabolic Fingerprint of Dual Body Fluids Deciphers Diabetic Retinopathy. Small. 2025;21(10). doi:10.1002/smll.202412195
BibTeX
@article{Wang2025,
author = {Wang, Yihan and Li, Shunxiang and Li, Tong and Wu, Jiao and Huang, Yida and Liu, Wanshan and Ding, Chunmeng and Huang, Lin and Xu, Xiaoyu and Wang, Yuning and Gu, Sai and Liu, Kun and Qian, Kun and Sun, Xiaodong},
title = {Metabolic Fingerprint of Dual Body Fluids Deciphers Diabetic Retinopathy},
journal = {Small},
year = {2025},
volume = {21},
number = {10},
doi = {10.1002/smll.202412195}
}
EUVIMED